Niki BioSolutions, Inc. Operating Lease, Impairment Loss
Niki BioSolutions, Inc. (NIKI) reported Operating Lease, Impairment Loss of $144.05 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseImpairmentLoss · last filed 2026-05-11
- Niki BioSolutions, Inc. operating lease, impairment loss for the quarter ending 2024-12-31 was $0.00.
- Niki BioSolutions, Inc. operating lease, impairment loss for the quarter ending 2024-09-30 was $0.00.
| Period end | Operating Lease, Impairment Loss 3 month | Operating Lease, Impairment Loss 6 month | Operating Lease, Impairment Loss 9 month | Operating Lease, Impairment Loss 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $144.05K S-4/A · filed 2026-05-11 | |
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $144.05K 6-K · filed 2026-01-22 | ||
| 2024-06-30 | $144.05K 6-K · filed 2025-10-08 | |||
| 2023-12-31 | $200.92K S-4/A · filed 2026-05-11 | |||
| 2023-06-30 | $200.92K 6-K · filed 2024-12-20 | |||
| 2020-12-31 | $330.44K 20-F · filed 2023-04-28 | |||
| 2020-06-30 | $330.44K 6-K · filed 2021-09-15 |